Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04512573 · ClinicalTrials.gov registry record
Patient Outcomes: Real World Evidence in Rheumatoid Arthritis (POWER)
A clinical trial, sponsored by CorEvitas.
- Completed
- Registry status
- 232
- Enrollment target
NCT04512573 is a clinical trial that has completed, run by CorEvitas. The registered enrollment target is 232 participants.
The verdict
NCT04512573 has completed, sponsored by CorEvitas.
- COMPLETED
- Registry status
- 232 participants
- Enrollment target
Study Summary
This is a prospective, real-world observational study in which patients with RA who are initiating treatment with a JAK inhibitor medication will self-report disease activity and treatment satisfaction measures using their own web-enabled device such as a smartphone. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2020-05-21 |
| Est. Completion | 2022-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04512573
The ClinicalTrials.gov registry entry for NCT04512573 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CorEvitas, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04512573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04512573 about?
NCT04512573 is a clinical study titled "Patient Outcomes: Real World Evidence in Rheumatoid Arthritis (POWER)". This is a prospective, real-world observational study in which patients with RA who are initiating treatment with a JAK inhibitor medication will self-report disease activity and treatment satisfaction measures using their own web-enabled device such as a smartphone. Secondary objectives include ana...
What is the current status of trial NCT04512573?
This trial is currently completed. The enrollment target is 232 participants. The study started on 2020-05-21. Estimated completion is 2022-08-31.
Who is sponsoring clinical trial NCT04512573?
This trial is sponsored by CorEvitas, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.